IL‐6 activates RANKL in FLS in the inflammatory microenvironments to promote osteoclast formation, resulting in bone erosion in RA patients.[149] In addition, IL‐6 increases MSC proliferation by promoting SATA3 phosphorylation. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.